iifl-logo-icon 1

Gufic BioSciences Ltd Cash Flow Statement

401.7
(-1.06%)
Feb 14, 2025|03:31:16 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Gufic BioScience FINANCIALS

Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

126.83

57.71

30.33

27.95

Depreciation

-17.13

-16.3

-8.35

-4.3

Tax paid

-30.99

-13.47

-7.47

-13.51

Working capital

30.22

-13.96

33.14

35.94

Other operating items

Operating

108.92

13.96

47.64

46.07

Capital expenditure

31.01

33.66

83.98

5.35

Free cash flow

139.93

47.62

131.62

51.42

Equity raised

327.31

239.13

145.03

60.34

Investing

0

0

0

0

Financing

15.23

-45.51

63.16

35.77

Dividends paid

0

0

0

0.38

Net in cash

482.48

241.25

339.82

147.92

Gufic BioScience : related Articles

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.